What you need to know about the new Mexico drug czar
Drug czar Alejandro Garza said on Wednesday that his department had been reviewing new regulations governing the use of Ritz-Carlton branded drugs.
“This is a serious concern,” Garza told reporters.
“In the last few days, the US Food and Drug Administration (FDA) has made changes to certain Ritz products in Mexico.”
Mexico’s national pharmacy association has been complaining about the Ritz brand for years.
In 2010, the Mexican government banned all imports of Rizs and Ritzs Superdrugs, claiming that Ritz was “toxic, dangerous and dangerous for the country”.
Garza was not immediately available for comment.
Mexican pharmacy association chief Luis Riz told AFP news agency that the government had not consulted him before implementing the regulations.
“I can tell you that this is not the first time we’ve had a similar situation, and I’m not the only one,” he said.
“Our industry is very healthy and it’s a very healthy industry.”
Ritz has a long history in Mexico, having started as a hotel chain in the city of Mexico City in the late 1960s.
In 2013, the company acquired a brand of health supplements, called “Oasis” by the US company, and has since expanded its business.
In January this year, the government said that Riz products would be phased out, with no further mention made of the brand.
The brand has long been seen as one of Mexico’s most popular brands, with sales increasing by 50% in 2016 to over $40bn, according to data from the market research firm Euromonitor International.
In the US, Ritz is the second most popular brand among consumers, behind Pepsi.
A study from marketing agency Ogilvy & Mather found that Mexican consumers were also more likely to use Ritz than other countries, and the brand was often listed as one one of the most-used health products in the US.